| Post Period (vs. Pre Period) |
---|
State | Outcome | DID Level1 | P-Value | DID Slope2 | P-Value |
---|
AZ | Any Hospitalization | − 0.19% | 0.702 | 0.01% | 0.710 |
Any ED Visit | −0.48% | 0.461 | −0.03% | 0.545 |
NJ | Any Hospitalization | −3.37% | 0.022* | −0.23% | 0.014* |
Any ED Visit | −2.87% | 0.057 | −0.18% | 0.103 |
TN | Any Hospitalization | 0.32% | 0.565 | −0.01% | 0.903 |
Any ED Visit | −1.38% | 0.156 | 0.05% | 0.562 |
- Notes: Linear regression used for utilization outcomes. Sample is person-months from 2010 to 2015. *denotes significance at p < .05. Regression covariates of interest were study Group (treatment vs. comparator); a linear monthly time trend, indicators and splines for the post period (2012–2015); and the interactions between these variables and Group. Other covariates included sex, age, race, indicator for SSI status, and 18 comorbidity indicators. Repeated measures adjusted for using Huber-White robust standard errors, clustering at the person level
- 1. Difference between treatment vs. comparator in the discontinuity (change in level) for the post period, measured using the interaction between Group & an indicator variable for the post period
- 2. Difference between treatment vs. comparator in the change in slope for the post period, measured using the interaction between Group & a spline variable for the post period